Detalhe da pesquisa
1.
Multimodality imaging for comprehensive non-invasive diagnosis of aorto-left ventricular tunnel in infancy.
Echocardiography
; 41(1): e15761, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38284686
2.
Evaluation of the therapeutic potential of cerebrolysin and/or lithium in the male Wistar rat model of Parkinson's disease induced by reserpine.
Metab Brain Dis
; 38(5): 1513-1529, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36847968
3.
Pyronaridine as a Bromodomain-Containing Protein 4-N-Terminal Bromodomain (BRD4-BD1) Inhibitor: In Silico Database Mining, Molecular Docking, and Molecular Dynamics Simulation.
Molecules
; 28(15)2023 Jul 28.
Artigo
Inglês
| MEDLINE | ID: mdl-37570684
4.
Naturally occurring plant-based anticancerous candidates as prospective ABCG2 inhibitors: an in silico drug discovery study.
Mol Divers
; 26(6): 3255-3277, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-35224675
5.
Exploring Natural Product Activity and Species Source Candidates for Hunting ABCB1 Transporter Inhibitors: An In Silico Drug Discovery Study.
Molecules
; 27(10)2022 May 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35630581
6.
Blue Biotechnology: Computational Screening of Sarcophyton Cembranoid Diterpenes for SARS-CoV-2 Main Protease Inhibition.
Mar Drugs
; 19(7)2021 Jul 13.
Artigo
Inglês
| MEDLINE | ID: mdl-34356816
7.
In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (Mpro) Inhibitors.
Molecules
; 26(7)2021 Apr 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33916461
8.
Monkeypox in children: what evidence do we have so far?
J Trop Pediatr
; 68(5)2022 08 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36130308
9.
Cerebrolysin potentiates the antidepressant effect of lithium in a rat model of depression.
J Psychiatr Res
; 172: 171-180, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38394763
10.
In silico drug repurposing and lipid bilayer molecular dynamics puzzled out potential breast cancer resistance protein (BCRP/ABCG2) inhibitors.
J Biomol Struct Dyn
; 41(16): 7651-7664, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36120948
11.
In-Silico Mining of the Toxins Database (T3DB) towards Hunting Prospective Candidates as ABCB1 Inhibitors: Integrated Molecular Docking and Lipid Bilayer-Enhanced Molecular Dynamics Study.
Pharmaceuticals (Basel)
; 16(7)2023 Jul 18.
Artigo
Inglês
| MEDLINE | ID: mdl-37513931
12.
SuperNatural inhibitors to reverse multidrug resistance emerged by ABCB1 transporter: Database mining, lipid-mediated molecular dynamics, and pharmacokinetics study.
PLoS One
; 18(7): e0288919, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37494356
13.
In silico drug discovery of SIRT2 inhibitors from natural source as anticancer agents.
Sci Rep
; 13(1): 2146, 2023 02 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36750593
14.
Chetomin, a SARS-CoV-2 3C-like Protease (3CLpro) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis.
Viruses
; 15(1)2023 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36680290
15.
Potential drug candidates as P-glycoprotein inhibitors to reverse multidrug resistance in cancer: an in silico drug discovery study.
J Biomol Struct Dyn
; 41(23): 13977-13992, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36883864
16.
In Silico Targeting Human Multidrug Transporter ABCG2 in Breast Cancer: Database Screening, Molecular Docking, and Molecular Dynamics Study.
Mol Inform
; 41(2): e2060039, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34491628
17.
Exploring Toxins for Hunting SARS-CoV-2 Main Protease Inhibitors: Molecular Docking, Molecular Dynamics, Pharmacokinetic Properties, and Reactome Study.
Pharmaceuticals (Basel)
; 15(2)2022 Jan 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35215266
18.
In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors.
J Biomol Struct Dyn
; 39(15): 5756-5767, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32684114
19.
Natural-like products as potential SARS-CoV-2 Mpro inhibitors: in-silico drug discovery.
J Biomol Struct Dyn
; 39(15): 5722-5734, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32643529
20.
Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease.
J Biomol Struct Dyn
; 39(14): 5129-5136, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32597315